Pictet Asset Management Holding SA Trims Stake in Revvity Inc. $RVTY

Pictet Asset Management Holding SA lessened its position in Revvity Inc. (NYSE:RVTY) by 34.2% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 897,343 shares of the company’s stock after selling 466,439 shares during the quarter. Pictet Asset Management Holding SA owned 0.80% of Revvity worth $78,561,000 at the end of the most recent reporting period.

A number of other large investors have also recently made changes to their positions in RVTY. Price T Rowe Associates Inc. MD grew its holdings in Revvity by 5.3% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 8,606,637 shares of the company’s stock valued at $832,693,000 after purchasing an additional 434,570 shares during the last quarter. EdgePoint Investment Group Inc. lifted its stake in Revvity by 26.3% in the third quarter. EdgePoint Investment Group Inc. now owns 8,574,280 shares of the company’s stock worth $751,536,000 after purchasing an additional 1,784,620 shares during the last quarter. Janus Henderson Group PLC boosted its position in shares of Revvity by 7.0% during the fourth quarter. Janus Henderson Group PLC now owns 8,161,171 shares of the company’s stock valued at $789,595,000 after buying an additional 533,912 shares during the period. Morgan Stanley boosted its position in shares of Revvity by 29.6% during the fourth quarter. Morgan Stanley now owns 2,844,464 shares of the company’s stock valued at $275,202,000 after buying an additional 650,083 shares during the period. Finally, Dimensional Fund Advisors LP grew its stake in shares of Revvity by 22.9% during the fourth quarter. Dimensional Fund Advisors LP now owns 2,612,116 shares of the company’s stock valued at $252,727,000 after buying an additional 486,159 shares during the last quarter. 86.65% of the stock is owned by hedge funds and other institutional investors.

Revvity Stock Performance

Revvity stock opened at $111.12 on Tuesday. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.41 and a current ratio of 1.72. The company has a market capitalization of $12.40 billion, a PE ratio of 53.17, a P/E/G ratio of 2.47 and a beta of 1.11. The company has a 50 day moving average price of $97.89 and a 200-day moving average price of $97.82. Revvity Inc. has a fifty-two week low of $81.22 and a fifty-two week high of $118.30.

Revvity (NYSE:RVTY) last announced its quarterly earnings data on Tuesday, May 5th. The company reported $1.06 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.02 by $0.04. The company had revenue of $711.12 million for the quarter, compared to analysts’ expectations of $704.07 million. Revvity had a return on equity of 8.00% and a net margin of 8.26%.Revvity’s revenue was up 7.0% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $1.01 earnings per share. Revvity has set its FY 2026 guidance at 5.200-5.300 EPS. As a group, equities analysts forecast that Revvity Inc. will post 5.25 earnings per share for the current year.

Revvity Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, August 7th. Stockholders of record on Friday, July 17th will be paid a dividend of $0.07 per share. The ex-dividend date is Friday, July 17th. This represents a $0.28 annualized dividend and a dividend yield of 0.3%. Revvity’s dividend payout ratio (DPR) is currently 13.40%.

Analyst Upgrades and Downgrades

A number of equities research analysts recently issued reports on the company. Weiss Ratings raised Revvity from a “sell (d)” rating to a “sell (d+)” rating in a research note on Wednesday, June 24th. Wolfe Research initiated coverage on Revvity in a research report on Tuesday, June 2nd. They issued a “peer perform” rating on the stock. TD Cowen increased their target price on Revvity from $115.00 to $120.00 and gave the stock a “buy” rating in a research note on Wednesday, May 6th. JPMorgan Chase & Co. decreased their target price on Revvity from $96.00 to $90.00 and set a “neutral” rating for the company in a research report on Wednesday, May 6th. Finally, Stifel Nicolaus lowered their target price on shares of Revvity from $110.00 to $100.00 and set a “hold” rating for the company in a research note on Wednesday, May 6th. Four analysts have rated the stock with a Buy rating, ten have given a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Hold” and an average target price of $108.33.

Revvity Company Profile

Revvity, Inc is a global provider of technology-enabled solutions for the life sciences, diagnostics and applied markets. The company develops and supplies a range of products and services, including reagents and consumables, laboratory instruments, workflow automation, software analytics and technical support. Its portfolio supports applications in drug discovery, genomics, cell biology research, environmental and food safety testing, industrial quality control and clinical diagnostics.

Tracing its heritage to Perkin-Elmer, founded in 1937, Revvity began trading on the New York Stock Exchange under the ticker symbol RVTY in January 2024 following a corporate rebranding.